Group One Trading’s Precision BioSciences DTIL Stock Holding History

Group One Trading’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7	Closed	-$105	–	7776
2023 Q2	$105	Hold	7	–	–	﹤0.01%	7509
2023 Q1	$151	Buy	+7	New	+$231	﹤0.01%	7013
2022 Q4	–	Sell	-23	Closed	-$1K	–	7422
2022 Q3	$1K	Sell	23 -67	-74%	-$3.18K	﹤0.01%	7293
2022 Q2	$4K	Buy	+90	New	+$5.28K	﹤0.01%	7185
2022 Q1	–	Sell	-7	Closed	-$1K	–	8166
2021 Q4	$1K	Sell	7 -550	-99%	-$154K	﹤0.01%	7977
2021 Q3	$193K	Sell	557 -176	-24%	-$59.6K	﹤0.01%	5214
2021 Q2	$275K	Buy	733 +233	+47%	+$70K	﹤0.01%	4879
2021 Q1	$155K	Sell	500 -2,010	-80%	-$704K	﹤0.01%	5259
2020 Q4	$628K	Buy	2,510 +2,133	+566%	+$523K	﹤0.01%	3073
2020 Q3	$70K	Buy	377 +280	+289%	+$55.7K	﹤0.01%	4422
2020 Q2	$24K	Sell	97 -320	-77%	-$70.1K	﹤0.01%	4740
2020 Q1	$75K	Buy	+417	New	+$109K	﹤0.01%	3487

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Group One Trading's DTIL Position: Q1 2024 in Review

Group One Trading held its Precision BioSciences (DTIL) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7236.

Group One Trading first reported a position in DTIL in Q4 2019 and has held it in 11 quarters since. The position peaked at $186K in Q3 2021. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

Group One Trading held 0 shares of Precision BioSciences worth $0 as of Q1 2024.
Group One Trading left its Precision BioSciences share count unchanged in Q1 2024.
Precision BioSciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2024, its #7236 holding.
Group One Trading first reported a position in Precision BioSciences in Q4 2019 and has held it in 11 quarters since.
Group One Trading's Precision BioSciences position peaked at $186K in Q3 2021.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.